Current Trend and Pro-survival Approaches for Augmenting Stem Cell Viability
- PMID: 32297579
- DOI: 10.2174/1389201021666200416130253
Current Trend and Pro-survival Approaches for Augmenting Stem Cell Viability
Abstract
Background: Stem cells are of two types: embryonic and adult stem cells and they act as a repair system by replenishing body tissue. Stem cells differentiate into different types of cells, such as neural, hematopoietic, adipose, etc. and are used for the treatment of various conditions like myocardial infarction, spinal cord injury, Parkinson's disease and diabetes.
Methods: This article focuses on recent research development that addresses the viability issues of stem cells. The efficiency of transplanted stem cells reduces due to conditions like hypoxia, inflammation, nutrient deprivation, immunogenicity, extracellular matrix loss on delivery and mechanical stress.
Results: To increase the viability of stem cells, techniques like scaffolds of stem cells with hydrogel or alginate, pre-conditioning, different routes of administration and encapsulation, are implemented.
Conclusion: For the protection of stem cells against apoptosis, different pathways, namely Phosphoinositide 3-Kinase (PI3K/AKT), Hypoxia-Inducible Factor (HIF1), Mitogen-Activated Protein Kinases (MAPK) and Hippo, are discussed.
Discussion: Activation of the PI3K/AKT pathway decreases the concentration of apoptotic factors, while the HIF pathway protects stem cells against the micro-environment of tissue (hypoxia).
Keywords: HIF1; PI3K/AKT; Viability; mesenchymal stem cell; preconditioning; pro-survival strategies.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Curcumin pretreatment protects against hypoxia/reoxgenation injury via improvement of mitochondrial function, destabilization of HIF-1α and activation of Epac1-Akt pathway in rat bone marrow mesenchymal stem cells.Biomed Pharmacother. 2019 Jan;109:1268-1275. doi: 10.1016/j.biopha.2018.11.005. Epub 2018 Nov 9. Biomed Pharmacother. 2019. PMID: 30551377
-
Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.J Cell Biochem. 2008 Jan 1;103(1):256-69. doi: 10.1002/jcb.21402. J Cell Biochem. 2008. PMID: 17497701
-
Berberine protects mesenchymal stem cells against hypoxia-induced apoptosis in vitro.Biol Pharm Bull. 2009 Aug;32(8):1335-42. doi: 10.1248/bpb.32.1335. Biol Pharm Bull. 2009. PMID: 19652370
-
The effects of mechanical loading on mesenchymal stem cell differentiation and matrix production.Vitam Horm. 2011;87:417-80. doi: 10.1016/B978-0-12-386015-6.00039-1. Vitam Horm. 2011. PMID: 22127254 Review.
-
[Hypoxic preconditioning of stem cells as a new approach to increase the efficacy of cell therapy for myocardial infarction].Vestn Ross Akad Med Nauk. 2013;(12):16-25. Vestn Ross Akad Med Nauk. 2013. PMID: 24741938 Review. Russian.
Cited by
-
Mechanotransduction regulates inflammation responses of epicardial adipocytes in cardiovascular diseases.Front Endocrinol (Lausanne). 2022 Dec 16;13:1080383. doi: 10.3389/fendo.2022.1080383. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36589802 Free PMC article. Review.
-
Advances in hydrogel for diagnosis and treatment for Parkinson's disease.Front Pharmacol. 2025 Feb 12;16:1552586. doi: 10.3389/fphar.2025.1552586. eCollection 2025. Front Pharmacol. 2025. PMID: 40012627 Free PMC article. Review.
-
Adipose-Derived Mesenchymal Stem Cells Combined With Extracellular Vesicles May Improve Amyotrophic Lateral Sclerosis.Front Aging Neurosci. 2022 May 18;14:830346. doi: 10.3389/fnagi.2022.830346. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35663577 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources